Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1

Interventions

Peripheral Blood Stem Cell Transplantation 5fludarabine phosphate 4Busulfan 4Tacrolimus 3Methotrexate 3Mycophenolic Acid 2Filgrastim 2Cyclophosphamide 2Antilymphocyte Serum 2thymoglobulin 1merphos 1fludarabine 1Whole-Body Irradiation 1Spectroscopy, Near-Infrared 1Resistance Training 1Pharmacogenomic Testing 1Oxycodone 1Ondansetron 1Mutation 1Music Therapy 1Moxifloxacin 1Morphine 1Methadone 1Melphalan 1Massage 1Imatinib Mesylate 1Fluorescent Antibody Technique 1Flow Cytometry 1Endoscopy, Digestive System 1Diet, Mediterranean 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Polycythemia Vera × Mutation × Clear all
NCT06923670 2025-05-15

Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Not yet recruiting
496 enrolled
Myeloid

Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡